Going global

Kovac, Matt; O'Driscoll, Cath
July 2006
ICIS Chemical Business;7/31/2006, Vol. 1 Issue 30, p26
Trade Publication
The article focuses on cross-border mergers and acquisitions by Indian chemical companies. In 2005, Indian companies made 103 cross-border acquisitions. This trend of overseas acquisitions is said to have been caused by India's competition with western nations in areas such as active ingredients for the pharmaceutical generic industry and advanced intermediates. Indian companies are expanding overseas due to the fact that companies from around the world outsource services.


Related Articles

  • A finequestion. Cerimele, Chris // ICIS Chemical Business;10/1/2007, Vol. 272 Issue 12, p13 

    The article focuses on common concerns among outsourcers of fine chemicals, and how does merger and acquisition (M&A) activity relate to those issues. According to Contract Pharma's 2006 Annual Outsourcing Survey, the top five factors include quality, timeliness, confidentiality, good...

  • INDIAN SCENE.  // Chemical Business;May2001, Vol. 15 Issue 5, p28 

    Presents news briefs on the Indian pharmaceutical and chemical sectors as of May 2001. Acquisition of the manufacturing facilities of Uniloids Ltd. by AVRA Laboratories; Expected market growth of the pharmaceutical industry; Rejection of the toll manufacturing agreement proposed by Pfizer Corp.

  • Fine Chem Manufacturers To Strive for Critical Mass. Jarvis, Lisa // Chemical Market Reporter;01/01/2001, Vol. 259 Issue 1, p4 

    Focuses on the mergers and acquisitions (M&A) activity in the fine chemicals industry in the United States. What prompted mergers among pharmaceutical industry; Factors forcing some traditional chemical companies to withdraw from the pharmaceutical business; Fine chemical companies whose M&A is...

  • FTC, Department of Justice to Speed Antitrust Reviews.  // Chemical Week;3/13/2002, Vol. 164 Issue 11, p5 

    Reports the division of roles in federal reviews of proposed business mergers by the U.S. Federal Trade Commission (FTC) and the antitrust division of Department of Justice (DOJ). Authority of FTC on the chemical and pharmaceutical industries; Focus of DOJ on the high-technology and...

  • Fine Chemicals Producers Need to Look Beyond Size. Jarvis, Lisa // Chemical Market Reporter;10/22/2001, Vol. 260 Issue 15, p8 

    Focuses on the effects on fine chemicals producers of the productivity issues facing the pharmaceutical industry as of October 22, 2001. Problems forcing the pharmaceutical industry to reexamine its operating model; Views of consultant Peter Pollak on mergers and acquisitions in the...

  • Reshaping CMC Development Services. Miller, Jim // Pharmaceutical Technology;Sep2005, Vol. 29 Issue 9, p102 

    Focuses on the impact of the lack of acquisition activity in the pharmaceutical sector on chemistry, manufacturing and control development services in the U.S. Changes in the way pharmaceutical companies buy contract services; Plan of pharmaceutical firms to reduce the number of suppliers they...

  • pharceuticals & fine chemicals.  // Chemical Week;7/5/2006, Vol. 168 Issue 23, p22 

    This article presents news briefs on the pharmaceuticals and fine chemicals sector of the chemical industry. Lannett has signed an agreement to outsource manufacturing of two unspecified drugs to contract manufacturer Olive Healthcare based in Mumbai, India. Meanwhile, Generic drugs firm Barr...

  • Introduction. Atlas, Lesly // Applied Clinical Trials;Apr2008 Supplement, Vol. 17, p4 

    The article focuses on the changes in the pharmaceutical business environment in the U.S. The author states that the industry is facing portfolio challenges, such as the pressure to increase mergers and acquisitions, drug withdrawals and the decrease in public faith regarding clinical trials....

  • CMO Investors Have More Money Than Places to Spend It. Miller, Jim // BioPharm International;Dec2015, Vol. 28 Issue 12, p16 

    The article offers information on contract manufacturing organization (CMO) industry consolidation. Topics discussed include challenges posed by large executives in CMO industry, shrinking number of companies to control increasing share of the revenues in the industry under consolidation,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics